Endometrial Cancer Trial, Recruiting NCT07078682 Sponsor: Zenchi, Inc. Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07078682
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female and between 20 and 45 years old
  • People with a body mass index (BMI) between 18.5 and 24.9 (a measure of body weight relative to height, considered a "normal" range)
  • People who have previously been told by a doctor that they have uterine fibroids (non-cancerous growths in the uterus)
  • People who are generally healthy and do not have any long-term health conditions that are uncontrolled
  • People who report moderate to severe discomfort during their period, such as pelvic cramps, bloating, mood swings, or fatigue
  • People who have been experiencing menstrual cramps for at least the past six months
  • People who take hormonal birth control, provided they have been taking it consistently for at least three months and still have a regular period
  • People who take over-the-counter supplements or herbal remedies, provided they have been taking them consistently for at least three months before the study starts and are willing to continue the same routine throughout the study
  • People willing to avoid starting any new medications, supplements, or products for the entire duration of the study
  • People willing to avoid any new supplements or herbal products aimed at affecting the menstrual cycle during the study
  • People willing to avoid receiving any new vaccines for the six-month study period
  • People who follow a regular, consistent exercise routine and are willing to keep that routine exactly the same throughout the study
  • People willing to avoid lifestyle changes that could affect their menstrual cycle during the study (such as starting or stopping hormonal birth control or changing their exercise habits)
  • People who use other therapies such as massage, chiropractic care, or acupuncture, and are willing to keep the frequency of those therapies the same throughout the study
  • People who live in the United States

Who may not be able to join:

  • People whose menstrual cycle is not regular (a regular cycle is defined here as 21–35 days)
  • People who do not experience menstrual cramps
  • People who follow an extreme dietary approach, such as dry fasting, water fasting, or a ketogenic diet
  • People who have lost a significant amount of weight in the three months before the study starts
  • People who are unwilling to stop taking any medications, herbal remedies, or supplements that could affect their menstrual cycle
  • People with existing long-term health conditions — including cancer or psychiatric disorders — that would make it difficult to follow the study's requirements
  • People with known severe allergic reactions
  • People with any known allergies or sensitivities to the ingredients in the study product
  • People who are pregnant, breastfeeding, trying to conceive, or who may become pregnant at any point during the study
  • People who are unwilling to follow the study's rules and requirements
  • People who have stopped, started, or changed their hormonal birth control in the past three months
  • People who have previously used a product called Elix Cycle Balance
  • People who currently smoke or have smoked in the past three months
  • People who have been diagnosed with any of the following conditions: PCOS, endometriosis, PMDD, adenomyosis, Hashimoto's thyroiditis, Grave's disease or other thyroid disorders, hyperprolactinemia, Cushing's disease, congenital adrenal hyperplasia, or any eating disorder (including anorexia, bulimia, orthorexia, or binge eating disorder)
  • People with a history of hormone-related conditions such as thyroid disorders or Type 1 or Type 2 diabetes
  • People with a history of high blood pressure, high cholesterol, or a blood clot in a vein
  • People with a BMI over 25 (considered overweight or obese)
  • People with ongoing pelvic pain caused by other conditions, such as infections, gut-related conditions, psychological conditions, fibromyalgia, or chronic fatigue syndrome
  • People who have had a hysterectomy, myomectomy, removal of both ovaries and fallopian tubes, or any other gynaecological medical or surgical treatment within the past six months
  • People with a history of an abnormal pap smear result
  • People with a history of gynaecological cancer or uterine abnormalities
  • People with recurring urinary tract infections or diagnosed gut conditions such as IBS, IBD, Crohn's disease, or ulcerative colitis
  • People who are currently taking part in another research study, or plan to do so at any point during the next 24 weeks
  • People who consume more than five alcoholic drinks per week
  • People who have received a vaccine within the past three months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 4242450284

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zenchi, Inc.
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 January 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in uterine fibroid-related symptom severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov